Kinaset Therapeutics
PrivateLast Round
Series B
Jan 10, 2026
Total Funding Raised
$171.5M
Momentum Score
50 /100
Company Overview
Kinaset Therapeutics is a biopharmaceutical company focused on developing innovative respiratory drugs aimed at providing less-invasive and cost-effective therapies for patients suffering from severe asthma and other intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinaset Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Kinaset Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 10, 2026 | ||||
| Series A Extension | Jul 18, 2022 | ||||
| Series A | Nov 30, 2020 |
Key People
Founding team and executive leadership
Kinaset Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| Sixty Degree Capital | Series B |
| EQT Life Sciences | Series B |
| SV Health Investors | Series A Extension |
| Gimv | Series B, Series A, Series A Extension |
| 5AM Ventures | Series B, Series A Extension, Series A |
| Accomplice | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Daniela Begolo from EQT Life Sciences joins the board.
- Jan 10, 2026
Peter B. Silverman joins the board, formerly of Forge Life Science Partners.
Kinaset Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinaset Therapeutics's valuation, stock price, and market status.
